Aligos Therapeutics Inc
F:5WK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
Multiples-Based Value
The Multiples-Based Value for
Aligos Therapeutics Inc (5WK) under the Base Case is 1.173 EUR.
Compared with the current market price of 10.725 EUR, the stock appears
Overvalued by 89% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.